ASLAN Pharmaceuticals Ltd. Operating Income 2018-2024 | ASLN
ASLAN Pharmaceuticals Ltd. operating income from 2018 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| ASLAN Pharmaceuticals Ltd. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-44 |
| 2022 | $-48 |
| 2021 | $-34 |
| 2020 | $-16 |
| 2019 | $-46 |
| 2018 | $-42 |
| 2017 | $-39 |
| 2016 | $-9 |
| ASLAN Pharmaceuticals Ltd. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-9 |
| 2023-12-31 | $-13 |
| 2023-09-30 | $-10 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-18 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-12 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-8 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-7 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-29 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-7 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-11 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-11 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-14 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-9 |
| 2017-03-31 | $-8 |
